C17 research
The C17 Research Network operates under the auspices of the C17 Council, a non-profit organization that represents the 16 academic pediatric oncology/hematology programs in the 17 centres across Canada. The network is set up to encourage and develop collaborative, multi-disciplinary, multi-site, Canadian research in pediatric hematology, oncology and hematological stem cell transplantation in furthering C17’s mission to improve health outcomes and quality of life for children and adolescents in Canada with cancer and blood disorders.
C17 Research Network Grant Competition
Twice a year in the spring and fall, the C17 Research Network holds a rigorous peer reviewed grant competition to fund and support projects in pediatric hematology, oncology and hematological stem cell transplantation. The grant review process is scientifically based and applicants are ranked on criteria such as clear statement of research, methodology, innovativeness and originality, evidence of collaboration and multidisciplinary approach and implications or application into clinical practice. The scope of projects considered include but are not limited to: phase I, II, III and pilot clinical trials; registries and population based studies; biological sample banks; quality of life and psychosocial research; health outcomes and health serviced research; and basic laboratory and translational research. By encouraging and funding multi-centre, multi-disciplinary research Canada wide, C17 is reducing barriers to access to research studies and thereby increasing treatment and research opportunities for all children to participate in the improving of health outcomes and the quality of life. Funding for the competition is partnered with the Childhood Cancer Foundation – Candlelighters Canada, The Kids With Cancer Society (Edmonton), The Sandra Sharpe Rhabdomyosarcoma Fund and the Aplastic Anemia and Myelodysplasia Association of Canada.
For further information on the C17 Research Network contact:
Dr. David Malkin |
Ms. Tammy Mah-Fraser |
